Isotopic Labeling of Biotherapeutics
HORIZON EUROPE - MSCA - DN - 2021 #101072780 01-02-2023 to 31-01-2027
The ISOBIOTICS project is a European interdisciplinary and intersectorial Doctoral Network that aims at training 10 + 1 PhD students (Doctoral Candidates, DCs) to devise new approaches of isotopic labeling of biological drugs.
_edit.jpg)
From left to the right : C.DUGAVE, M.SCHOU, F.TARAN, B.KUHNAST, C.ELMORE, R.GOMES, J.ALICH, C.PETERS, D.GUGLIELMINOTTI, G.PIETERS, S.SPECKLIN, A.SALLUSTRAU, B.ATTILI, P.GEORGE, V.DERDAU, R.RIOBOO, A.IDOCIN, T.FUNDER, A.SCHICK, M.GRACIA, D.AUDISIO, P.GEORGE, M.PAPAVASILEIOU, A.CUENCA, E.SANLES, E.MARTINELLI, M.GUINGAND, A.POH , S.FEUILLASTRE
@Check Meeting; Photo by: S.UTEKAR
ISOBIOTICS involves 6 Beneficiaries (5 granted by EU + 1 granted by UK) and 9 Associated Partners, and is coordinated by Dr. Christophe DUGAVE at the Joliot Institute for Life Sciences at the Fudamental Research Division of CEA.
This project has received funding from the European Union's Horizon Europe research and innovation programme under the Marie Sklodowska-Curie Actions grant agreement No 101072780.
Here below is a simple and didactic video explaining what are isotopes (© Ricochet Science)
In the video below, Dr. Davide Audisio and Dr. Bertrand Kuhnast talk about radiochemistry at CEA (© CEA)
As an illustration, you can watch this video produced by ANSTO News (© ansto.gov.au)
Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Horizon Europe Funding Program. Neither the European Union nor the granting authority can be held responsible for them.